Firm in genetically modified insulin breakthrough

Insulin produced by genetically modified plants – with a human gene added – could be on the market in three years, a Canadian company has claimed.

Sembiosys said it has made scientific breakthroughs and found a short cut through current drug regulations.  The firm’s CEO Andrew Baum said his company could become one of the first to sell a plant-based pharmaceutical.

However, critics believe that these products pose greater environmental and health risks than GM food crops.

More info:  BBC News article

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: